Exelixis Inc. Common Stock vs Ventas Inc. Common Stock — how do they compare? Exelixis Inc. Common Stock trades at $60.35 (market cap $14.62B), while Ventas Inc. Common Stock trades at $82.92 (market cap $41.94B). The key difference: Ventas Inc. Common Stock is far larger — about 2.9× Exelixis Inc. Common Stock's market cap, and Ventas Inc. Common Stock pays a 2.54% dividend while Exelixis Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 0 Days and Ventas Inc. Common Stock for 0 Days on average.
| EXEL | VTR | |
|---|---|---|
Market Cap | $14.62B | $41.94B |
Volume | 2,684,957 | 4,588,793 |
Sector | Health | Real Estate |
52-Week High | $59.13 | $100.53 |
52-Week Low | $34.54 | $67.45 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $13.95B | $54.66B |
Dividend Yield | — | 2.54% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →Ventas is a real estate investment trust focused on healthcare properties. Its portfolio includes senior housing, medical office buildings, and research-related facilities.
Read more on VTR →